<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03592290</url>
  </required_header>
  <id_info>
    <org_study_id>2000020057</org_study_id>
    <nct_id>NCT03592290</nct_id>
  </id_info>
  <brief_title>Hemodynamics Monitoring During Lower Body Negative Pressure (LBNP) Induced Controlled Hypovolemia</brief_title>
  <acronym>LBPN</acronym>
  <official_title>Hemodynamics Monitoring During Lower Body Negative Pressure (LBNP) Induced Controlled Hypovolemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To monitor the changes in central and peripheral monitors/waveforms during gradual&#xD;
      hypovolemia induced by lower body negative pressure in healthy volunteers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary aim of this research is to identify the most robust site for monitoring&#xD;
      hypovolemia as well as assess changes in peripheral waveforms monitored by the pulse oximeter&#xD;
      collected from different sites (finger, ear, forehead, and nose), blood pressure, cerebral&#xD;
      oximetry and peripheral venous pressure during gradual hypovolemia induced by lower body&#xD;
      negative pressure (LBNP) in healthy volunteers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 15, 2017</start_date>
  <completion_date type="Anticipated">November 2022</completion_date>
  <primary_completion_date type="Actual">January 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identify the most robust site for monitoring hypovolemia utilizing pulse oximeter waveforms.</measure>
    <time_frame>2 years</time_frame>
    <description>Data will be summarized using mean (SD) for normally distributed data, median (interquartile range) for non-normal data.&#xD;
linear regression method will be used to model the changes of our dependent variable from baseline during blood loss.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Examine the relationship between central hemodynamic changes (cardiac output) with changes in respiratory variability of PPG waveforms collected from different sites during hypovolemia and fluid resuscitation</measure>
    <time_frame>2 years</time_frame>
    <description>Data will be summarized using mean (SD) for normally distributed data, median (interquartile range) for non-normal data.&#xD;
linear regression method will be used to model the changes of our dependent variable from baseline during blood loss.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Hypovolemia</condition>
  <condition>Hemodynamic Instability</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Lower body negative pressure</intervention_name>
    <description>We will be monitoring the changes in central and peripheral monitors/waveforms during gradual hypovolemia induced by lower body negative pressure in healthy volunteers.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy volunteers aged 20-45 with no history of heart disease, diabetes, or hypertension.&#xD;
        Pregnant women will be excluded.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        * Healthy volunteers aged 20-45 with&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Under 20 years of age&#xD;
&#xD;
          -  Subjects with coronary artery disease, diabetes, epilepsy and hypertension&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aymen Alian, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>John B. Pierce Laboratory</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>June 13, 2018</study_first_submitted>
  <study_first_submitted_qc>July 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2018</study_first_posted>
  <last_update_submitted>November 24, 2020</last_update_submitted>
  <last_update_submitted_qc>November 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypovolemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

